EDESA BIOTECH, INC. Other Noncash Income (Expense)
EDESA BIOTECH, INC. (EDSA) reported Other Noncash Income (Expense) of $822.67 thousand for the 12-month period ending 2022-09-30, per its 10-K filed 2022-12-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2022-12-16
- EDESA BIOTECH, INC. other noncash income (expense) for fiscal 2022 was $822.67K, a 92.04% decline from fiscal 2021.
- EDESA BIOTECH, INC. other noncash income (expense) for fiscal 2021 was $10.34M.
| Period end | Other Noncash Income (Expense) 12 month |
|---|---|
| 2022-09-30 | $822.67K 10-K · filed 2022-12-16 |
| 2021-09-30 | $10.34M 10-K · filed 2022-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |